Dipharma completes R&D expansion
Italian CDMO Dipharma Francis has completed of the expansion of its R&D centre for small molecules at its headquarters site in Baranzate, near Milan. This boosts lab space for analytical R&D activities by over 130%. The equipment includes a new 500 MHz NMR and the centre is managed via cloud-based integrated data systems.
Dipharma added that the expansion will both strengthen its analytical capabilities and “broaden expertise for the development of new organic synthesis methods and technology to target and offer a wider range of new APIs and advanced intermediates”. Its R&D team in Italy has grown by over 40% in Italy since 2020, with further expansion in the US.
RELATED ARTICLES
Blue Wolf Capital Partners, a US-based private equity firm, has agreed to acquire seven Recipharm sites from EQT Private Equity, subject to regulatory approval in a deal that should close in Q4.
Jubilant Ingrevia has commissioned a new 2,000 tonnes/year facility for diketene derivatives at Gajraula in India’s Uttar Pradesh state. The company’s supplies these to the pharmaceuticals, agrochemicals and other industries, including the US and the EU.
EuroAPI has suspended all API production at its site in Brindisi, Italy, until further notice. This followed an internal audit in which “quality control deficiencies due to potential local misconduct” were identified. These are being further investigated.
W.R. Grace has formally opened an expansion of the pharmaceutical CDMO expansion project it began 21 months ago at its site in South Haven, Michigan.
Almac Group has announced the completion of two new purpose-built facilities at its headquarters in Craigavon, Northern Ireland. The total investment is about $400 million and is part of a global investment programme announced in June 2022.
Noramco, an API supplier specialised in controlled substances, has launched Noramco Group, which it describes as a “comprehensive North American-based supply chain solution” for clinical and commercial APIs and drug products. Noramco Group unites the capabilities of three subsidiaries:
